Home › Metastatic Cancer › North Carolina › Raleigh
Metastatic Cancer clinical trials in Raleigh, NC
4 studies for Metastatic Cancer are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Duke Women's Cancer Care Raleigh, Raleigh
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Duke Cancer Center Raleigh, Raleigh
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Investigative Site #131, Raleigh
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
RecruitingObservational study
- Duke Women's Cancer Care Raleigh, Raleigh
- Duke Raleigh Hospital, Raleigh
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Raleigh
- Heart Failure7 studies
- Coronary Artery Disease6 studies
- Obesity6 studies
- Type 2 Diabetes6 studies
- Macular Degeneration6 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Endometrial Cancer5 studies
- Stroke5 studies
- Kidney Failure4 studies
- Diabetes4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.